Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|June 9, 2016
Melanoma Cells Can Adopt the Phenotype of Stromal Fibroblasts and Macrophages by Spontaneous Cell Fusion in VitroLajos V Kemény, Zsuzsanna Kurgyis, Tünde Buknicz, et al.Diagnostics (Basel, Switzerland)|January 22, 2024
Challenges in the Diagnosis of Cutaneous MastocytosisKnut Brockow, Rebekka Karolin Bent, Simon Schneider, et al.Diagnostics (Basel, Switzerland)|June 13, 2025
Reply to Urbina, F.; Benavides, A. Telangiectatic Mastocytosis: If It Is Not Mastocytosis, What Is It? Comment on "Brockow et al. Challenges in the Diagnosis of Cutaneous Mastocytosis. <i>Diagnostics</i> 2024, <i>14</i>, 161"Knut Brockow, Rebekka Karolin Bent, Simon Schneider, et al.Nature|November 30, 2017
Erratum: PD-1 is a haploinsufficient suppressor of T cell lymphomagenesisTim Wartewig, Zsuzsanna Kurgyis, Selina Keppler, et al.Nature|November 17, 2017
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesisTim Wartewig, Zsuzsanna Kurgyis, Selina Keppler, et al.International Journal of Molecular Sciences|June 25, 2016
Melanoma-Derived BRAF(V600E) Mutation in Peritumoral Stromal Cells: Implications for in Vivo Cell FusionZsuzsanna Kurgyis, Lajos V Kemény, Tünde Buknicz, et al.Proceedings of the National Academy of Sciences of the United States of America|August 28, 2019
The uric acid crystal receptor Clec12A potentiates type I interferon responsesKai Li, Konstantin Neumann, Vikas Duhan, et al.Dermatology and Therapy|August 18, 2025
Cancer Risk in Vitiligo: No Evidence of Increased Prevalence-A Systematic Review and Meta-analysisAlzahra A Mohammed, Anna S Lengyel, Fanni A Meznerics, et al.Dermatology and Therapy|May 7, 2025
Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysisAlzahra A Mohammed, Anna S Lengyel, Fanni A Meznerics, et al.Science Advances|March 15, 2023
Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapyLarsen Vornholz, Sophie E Isay, Zsuzsanna Kurgyis, et al.Pageof 2